Abbott Laboratories Management
Management Kriterienprüfungen 3/4
Abbott Laboratories CEO ist Robert Ford , ernannt in Oct 2018, hat eine Amtszeit von 6.08 Jahren. Die jährliche Gesamtvergütung beträgt $23.27M , bestehend aus 6.4% Gehalt und 93.6% Boni, einschließlich Aktien und Optionen des Unternehmens. besitzt direkt 0.024% der Aktien des Unternehmens, im Wert von $48.95M . Die durchschnittliche Betriebszugehörigkeit des Managementteams und des Verwaltungsrats beträgt 5.5 Jahre bzw. 5.8 Jahre.
Wichtige Informationen
Robert Ford
Geschäftsführender
US$23.3m
Gesamtvergütung
| Prozentsatz des Geschäftsführergehalts | 6.4% |
| Amtszeit als Geschäftsführer | 6.1yrs |
| Eigentum des Geschäftsführers | 0.02% |
| Durchschnittliche Amtszeit des Managements | 5.5yrs |
| Durchschnittliche Amtszeit der Vorstandsmitglieder | 5.8yrs |
Jüngste Management Updates
Recent updates
Investors Will Want Abbott Laboratories' (NYSE:ABT) Growth In ROCE To Persist
Oct 31
Abbott Laboratories: Long-Term Optimism, Short-Term Overvaluation
Oct 21Abbott: Challenging Comparables, Unappealing Value Limit The Incentive To Go Long Ahead Of Q3 Event
Oct 14Does Abbott Laboratories (NYSE:ABT) Have A Healthy Balance Sheet?
Oct 11Why We're Not Concerned About Abbott Laboratories' (NYSE:ABT) Share Price
Sep 27Abbott Laboratories: Cardiovascular Disease Has Been A Tailwind, But Things Could Change
Sep 11A Look At The Intrinsic Value Of Abbott Laboratories (NYSE:ABT)
Aug 16Abbott Laboratories: Driving Value By Scaling Innovations
Aug 13Abbott Laboratories: A Strong Healthcare Stock For Long-Term Dividend Growth Investors
Aug 05Abbott Laboratories: When Double-Digit Device Growth Apparently Isn't Enough
Jul 13These 4 Measures Indicate That Abbott Laboratories (NYSE:ABT) Is Using Debt Reasonably Well
Jul 01Abbott Laboratories (NYSE:ABT) Is Doing The Right Things To Multiply Its Share Price
Jun 18Investors Still Waiting For A Pull Back In Abbott Laboratories (NYSE:ABT)
Jun 04Abbott Laboratories: Why I Agree With Wall Street On This One
Jun 04Abbott Laboratories: Buying More Of This Top-Notch Dividend Growth Stock
May 18Abbott Laboratories: Organic Growth Will Be Key To Q1 Earnings
Apr 17Estimating The Intrinsic Value Of Abbott Laboratories (NYSE:ABT)
Apr 15Abbott Laboratories: Buy This World-Class Dividend Growth Stock Now
Mar 21Abbott Laboratories (NYSE:ABT) Might Have The Makings Of A Multi-Bagger
Mar 19Here's Why Abbott Laboratories (NYSE:ABT) Can Manage Its Debt Responsibly
Mar 06Abbott Labs' Reversal Is Here - CGM Tailwinds In 2024
Feb 27Abbott Laboratories' (NYSE:ABT) Shares May Have Run Too Fast Too Soon
Feb 08The King Is Back: Abbott Laboratories' Path To >11% Annual Returns
Jan 29The Abbott Laboratories (NYSE:ABT) Full-Year Results Are Out And Analysts Have Published New Forecasts
Jan 26Analyse der Geschäftsführervergütung
| Datum | Gesamtvergütung | Gehalt | Unternehmensgewinne |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | US$6b |
| Jun 30 2024 | n/a | n/a | US$6b |
| Mar 31 2024 | n/a | n/a | US$6b |
| Dec 31 2023 | US$23m | US$2m | US$6b |
| Sep 30 2023 | n/a | n/a | US$5b |
| Jun 30 2023 | n/a | n/a | US$5b |
| Mar 31 2023 | n/a | n/a | US$6b |
| Dec 31 2022 | US$22m | US$2m | US$7b |
| Sep 30 2022 | n/a | n/a | US$8b |
| Jun 30 2022 | n/a | n/a | US$9b |
| Mar 31 2022 | n/a | n/a | US$8b |
| Dec 31 2021 | US$25m | US$1m | US$7b |
| Sep 30 2021 | n/a | n/a | US$7b |
| Jun 30 2021 | n/a | n/a | US$6b |
| Mar 31 2021 | n/a | n/a | US$6b |
| Dec 31 2020 | US$20m | US$1m | US$4b |
| Sep 30 2020 | n/a | n/a | US$3b |
| Jun 30 2020 | n/a | n/a | US$3b |
| Mar 31 2020 | n/a | n/a | US$4b |
| Dec 31 2019 | US$12m | US$1m | US$4b |
| Sep 30 2019 | n/a | n/a | US$3b |
| Jun 30 2019 | n/a | n/a | US$3b |
| Mar 31 2019 | n/a | n/a | US$3b |
| Dec 31 2018 | US$8m | US$784k | US$2b |
| Sep 30 2018 | n/a | n/a | US$802m |
| Jun 30 2018 | n/a | n/a | US$812m |
| Mar 31 2018 | n/a | n/a | US$365m |
| Dec 31 2017 | US$5m | US$675k | US$344m |
Vergütung im Vergleich zum Markt: RobertDie Gesamtvergütung ($USD23.27M) liegt über dem Durchschnitt von Unternehmen ähnlicher Größe auf dem Markt US ($USD12.67M).
Entschädigung vs. Einkommen: RobertDie Vergütung des Vorstandsvorsitzenden entsprach im vergangenen Jahr der Unternehmensleistung.
Geschäftsführer
Robert Ford (50 yo)
6.1yrs
Amtszeit
US$23,268,171
Vergütung
Mr. Robert B. Ford has been the Chief Executive Officer of Abbott Laboratories since March 31, 2020 and also serves as its Chairman of the Board since December 10, 2021. He has been President at Abbott Lab...
Führungsteam
| Name | Position | Amtszeit | Vergütung | Eigentümerschaft |
|---|---|---|---|---|
| Chairman of the Board | 6.1yrs | US$23.27m | 0.024% $ 49.0m | |
| CFO & Executive VP of Finance | 1.2yrs | US$3.32m | 0.0023% $ 4.6m | |
| Executive VP | 11.8yrs | US$7.42m | 0.011% $ 21.7m | |
| Executive VP and Group President of Established Pharmaceuticals & Nutritional Products | 10.2yrs | US$5.93m | 0.0073% $ 14.7m | |
| Executive VP & Group President of Medical Devices | 5.8yrs | US$5.50m | 0.0035% $ 7.2m | |
| Senior VP of Business & Technology Services and Chief Information Officer | less than a year | keine Daten | keine Daten | |
| Vice President of Investor Relations. | no data | keine Daten | keine Daten | |
| VP and Chief Ethics & Compliance Officer | no data | keine Daten | keine Daten | |
| Senior Vice President of Commercial Operations | 1.8yrs | keine Daten | keine Daten | |
| Executive Vice President of Human Resources | 5.3yrs | keine Daten | 0.0059% $ 12.0m | |
| Senior Vice President of Global Marketing & External Affairs | no data | keine Daten | keine Daten | |
| Executive Vice President of Diabetes Care | 9.4yrs | keine Daten | 0.0042% $ 8.4m |
5.5yrs
Durchschnittliche Betriebszugehörigkeit
54yo
Durchschnittliches Alter
Erfahrenes Management: ABTDas Führungsteam des Unternehmens verfügt über eine langjährige Erfahrung (5.5 ).
Vorstandsmitglieder
| Name | Position | Amtszeit | Vergütung | Eigentümerschaft |
|---|---|---|---|---|
| Chairman of the Board | 5yrs | US$23.27m | 0.024% $ 49.0m | |
| Independent Director | 7.8yrs | US$349.29k | 0.39% $ 786.8m | |
| Independent Director | 7.8yrs | US$341.96k | 0.00020% $ 406.8k | |
| Lead Independent Director | 12.9yrs | US$405.96k | 0.00027% $ 549.1k | |
| Independent Director | 3.6yrs | US$337.96k | 0% $ 0 | |
| Independent Director | 16.1yrs | US$441.44k | 0% $ 0 | |
| Independent Director | 1.6yrs | US$283.96k | 0% $ 0 | |
| Independent Director | 6.4yrs | US$331.96k | 0.00018% $ 366.1k | |
| Independent Director | 12.9yrs | US$362.60k | 0.00015% $ 305.1k | |
| Independent Director | 2.2yrs | US$354.96k | 0% $ 0 | |
| Independent Director | 5.2yrs | US$331.19k | 0% $ 0 | |
| Independent Director | 3.3yrs | US$356.96k | 0% $ 0 |
5.8yrs
Durchschnittliche Betriebszugehörigkeit
62yo
Durchschnittliches Alter
Erfahrener Vorstand: ABTDie Vorstandsmitglieder gelten als erfahren (5.8 Jahre durchschnittliche Amtszeit).